Patents by Inventor Michelle Cronin

Michelle Cronin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965040
    Abstract: The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: April 23, 2024
    Assignee: RA PHARMACEUTICALS, INC.
    Inventors: Michelle Denise Hoarty, Ketki Ashok Dhamnaskar, Daniel Elbaum, Kristopher Josephson, Kelley Cronin Larson, Zhong Ma, Nathan Ezekiel Nims, Alonso Ricardo, Kathleen Seyb, Guo-Qing Tang, Douglas A. Treco, Zhaolin Wang, Ping Ye, Hong Zheng, Sarah Jacqueline Perlmutter, Robert Paul Hammer
  • Publication number: 20150359909
    Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
    Type: Application
    Filed: July 14, 2015
    Publication date: December 17, 2015
    Inventors: Gerald O'SULLIVAN, Mark TANGNEY, Douwe VAN SINDEREN, Michelle CRONIN
  • Patent number: 9103831
    Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: August 11, 2015
    Assignee: University College Cork-National University of Ireland Cork
    Inventors: Mark Tangney, Douwe Van Sinderen, Michelle Cronin, Brendan O'Sullivan
  • Publication number: 20120189550
    Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
    Type: Application
    Filed: July 16, 2010
    Publication date: July 26, 2012
    Applicant: UNIVERSITY COLLEGE CORK-NATIONAL UNIVERSITY OF IRELAND, CORK
    Inventors: Gerald O'Sullivan, Mark Tangney, Douwe Van Sinderen, Michelle Cronin